Catalyst Wire Dossier Catalyst Wire Dossier

Cell-derived subunit trivalent nonadjuvanted influenza vaccine (study vaccine)

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cell-derived subunit trivalent nonadjuvanted influenza vaccine (study vaccine), covering 2014-01-27 to 2014-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above [Phase 3]

See pricing